Incurring Development Expenses. Subject to Section 4.2(a)(i)[***]-(6), each Party shall initially bear all Development Expenses it incurs as set forth in each Product Work Plan (or as set forth in Exhibit 2.1(a)(1) prior to approval of such Product Work Plan) for each Product. Without limiting the foregoing, [***]. [***]. [***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.
Appears in 1 contract
Sources: Collaboration Agreement (Momenta Pharmaceuticals Inc)
Incurring Development Expenses. Subject to Section 4.2(a)(i)[***]-(64.2(a)(i)(2)-(6), each Party shall initially bear all Development Expenses it incurs as set forth in each Product Work Plan (or as set forth in Exhibit 2.1(a)(1) prior to approval of such Product Work Plan) for each Product. Without limiting the foregoing, [***]. [***]. [***] Certain information in this document has been omitted and filed separately the Party primarily responsible for managing execution, or contracting with Third Parties for the Securities and Exchange Commission. Confidential treatment has been requested with respect conduct, of a Development Activity under Sections 2.2 or 2.3 shall initially bear all Development Expenses owed to the omitted portionsThird Parties for such Development Activity.
Appears in 1 contract
Sources: Collaboration Agreement (Momenta Pharmaceuticals Inc)